JAGUAR HEALTH, INC. Operating Lease, Payments
JAGUAR HEALTH, INC. (JAGX) reported Operating Lease, Payments of $117.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-19
- JAGUAR HEALTH, INC. operating lease, payments for the quarter ending 2026-06-30 was $68.00K, a 8.11% decline year-over-year.
- JAGUAR HEALTH, INC. operating lease, payments for the quarter ending 2026-03-31 was $49.00K, a 22.22% decline year-over-year.
- JAGUAR HEALTH, INC. operating lease, payments for the quarter ending 2025-12-31 was $62.00K, a 45.61% decline year-over-year.
- JAGUAR HEALTH, INC. operating lease, payments for the quarter ending 2025-09-30 was $73.00K, a 38.66% decline year-over-year.
- JAGUAR HEALTH, INC. operating lease, payments for fiscal 2025 was $272.00K, a 39.69% decline from fiscal 2024.
- JAGUAR HEALTH, INC. operating lease, payments for fiscal 2024 was $451.00K, a 14.47% increase from fiscal 2023.
- JAGUAR HEALTH, INC. operating lease, payments for fiscal 2023 was $394.00K, a 25.08% increase from fiscal 2022.
- JAGUAR HEALTH, INC. operating lease, payments for fiscal 2022 was $315.00K, a 199.26% increase from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 3 month as first filed | Operating Lease, Payments 6 month | Operating Lease, Payments 6 month as first filed | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month | Operating Lease, Payments 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $68.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | $117.00K 10-Q · filed 2026-08-19 | $179.00K derived: sum of 3 quarters · filed 2026-08-19 | $252.00K derived: sum of 4 quarters · filed 2026-08-19 | |||
| 2026-03-31 | $49.00K 10-Q · filed 2026-05-20 | $111.00K derived: sum of 2 quarters · filed 2026-05-20 | $184.00K derived: sum of 3 quarters · filed 2026-05-20 | $258.00K derived: sum of 4 quarters · filed 2026-08-19 | |||
| 2025-12-31 | $62.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-07 | $135.00K derived: sum of 2 quarters · filed 2026-04-07 | $209.00K derived: sum of 3 quarters · filed 2026-08-19 | $272.00K 10-K · filed 2026-04-07 | |||
| 2025-09-30 | $73.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $147.00K derived: sum of 2 quarters · filed 2026-08-19 | $210.00K 10-Q · filed 2025-11-14 | $324.00K derived: sum of 4 quarters · filed 2026-08-19 | |||
| 2025-06-30 | $74.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | $137.00K 10-Q · filed 2026-08-19 | $251.00K derived: sum of 3 quarters · filed 2026-08-19 | $370.00K derived: sum of 4 quarters · filed 2026-08-19 | |||
| 2025-03-31 | $63.00K 10-Q · filed 2026-05-20 | $177.00K derived: sum of 2 quarters · filed 2026-05-20 | $296.00K derived: sum of 3 quarters · filed 2026-05-20 | $178.00K derived: sum of 4 quarters · filed 2026-05-20 | |||
| 2024-12-31 | $114.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-07 | $233.00K derived: sum of 2 quarters · filed 2026-04-07 | $115.00K derived: sum of 3 quarters · filed 2026-04-07 | $451.00K 10-K · filed 2026-04-07 | |||
| 2024-09-30 | $119.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $1.00K derived: sum of 2 quarters · filed 2025-11-14 | $337.00K 10-Q · filed 2025-11-14 | $431.00K derived: sum of 4 quarters · filed 2025-11-14 | |||
| 2024-06-30 | -$118.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $218.00K 10-Q · filed 2025-08-14 | $312.00K derived: sum of 3 quarters · filed 2025-08-14 | $437.00K derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | $336.00K 10-Q · filed 2025-05-15 | $430.00K derived: sum of 2 quarters · filed 2025-05-15 | $555.00K derived: sum of 3 quarters · filed 2025-05-15 | $677.00K derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | $94.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $219.00K derived: sum of 2 quarters · filed 2025-03-31 | $341.00K derived: sum of 3 quarters · filed 2025-03-31 | $394.00K 10-K · filed 2025-03-31 | |||
| 2023-09-30 | $125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $247.00K derived: sum of 2 quarters · filed 2024-11-13 | $300.00K 10-Q · filed 2024-11-13 | $231.00K derived: sum of 4 quarters · filed 2024-11-13 | |||
| 2023-06-30 | $122.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $175.00K 10-Q · filed 2024-08-13 | $107.00K 10-Q · filed 2023-08-14 | $106.00K derived: sum of 3 quarters · filed 2024-08-13 | $169.00K derived: sum of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | $53.00K 10-Q · filed 2024-05-14 | -$16.00K derived: sum of 2 quarters · filed 2024-05-14 | $47.00K derived: sum of 3 quarters · filed 2024-05-14 | $263.00K derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | -$69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$6.00K derived: sum of 2 quarters · filed 2024-04-01 | $210.00K derived: sum of 3 quarters · filed 2024-04-01 | $315.00K 10-K · filed 2024-04-01 | |||
| 2022-09-30 | $63.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $279.00K derived: sum of 2 quarters · filed 2023-11-14 | $384.00K 10-Q · filed 2023-11-14 | $489.26K derived: sum of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | $216.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $321.00K 10-Q · filed 2023-08-14 | $426.26K derived: sum of 3 quarters · filed 2023-08-14 | $426.26K derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | $105.00K 10-Q · filed 2023-05-15 | $105.26K 10-Q · filed 2022-05-10 | $210.26K derived: sum of 2 quarters · filed 2023-05-15 | $210.26K derived: sum of 3 quarters · filed 2023-05-15 | $210.26K derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $105.26K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $105.26K derived: sum of 2 quarters · filed 2023-03-24 | $105.26K derived: sum of 3 quarters · filed 2023-03-24 | $105.26K 10-K · filed 2023-03-24 | $105.26M 10-K · filed 2022-03-11 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | ||||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-22 | $0.00 10-Q · filed 2022-08-22 | |||||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-10 | ||||||
| 2020-12-31 | $357.08M 10-K · filed 2022-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |